Federal Register #DEA-1763

DEA Notice: Irvine Labs, Inc. Application to Import Controlled Substances

This notice concerns Irvine Labs, Inc.'s application to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - Applicant/Vendor: - Irvine Labs, Inc. - Products/Controlled Substances Requested: - Marihuana Extract (Drug Code 7350) - Marihuana (Drug Code 7360) - Tetrahydrocannabinols (Drug Code 7370) - Authorization is limited to importation of raw plant material and extracts - Purpose of Importation: - Internal research - Clinical trials - Analytical purposes - Distribution to customers - Unique/Notable Requirements: - No authorization for importation of finished dosage forms for commercial sale - Only raw plant material and extracts permitted - Public may submit comments or request a hearing regarding the application - No other OEMs or vendors are mentioned - No specific quantities or part numbers provided

Description

Irvine Labs, Inc. has applied to be registered as an importer of basic classes of controlled substances. The company plans to import bulk substances to support internal research, clinical trials, analytical purposes, and distribution to their customers. The application includes specific drug codes such as Marihuana Extract, Marihuana, and Tetrahydrocannabinols, with authorization limited to raw plant material and extracts. Comments or objections to the proposed registration may be submitted electronically by October 14, 2026, and requests for a hearing must also be filed by this date.

View original listing